Hologic CFO McMahon jumps ship to Agilent | Personnel Moves

Hologic (NSDQ:HOLX) said yesterday that its CFO Bob McMahon is leaving to take up a CFO role at Agilent Technologies.

The Marlborough, Mass.-based company said that its current chief accounting officer Karleen Oberton has been lifted to CFO, effective today.

“Bob has made tremendous contributions to Hologic over the last four years, and we wish him all the best in his new role. At the same time, we are excited to promote Karleen to CFO. She has a deep knowledge of our business and people based on more than 12 years of experience at the company, and has been a great partner to our divisions. She has been instrumental in our efforts both to drive profitable growth, and to strengthen our balance sheet and cash flows,” chair, prez & CEO Steve MacMillan said in a press release.

Prior to joining Hologic in 2006, Oberton served as senior corporate controller from 2004 to 2006, and acted as Ernst & Young life sceince practice senior audit manager before that.

BD taps Campion as interventional prez, EVP

Becton Dickinson & Co. (NYSE:BDX) said today it named Simon Campion as its new interventional segment president and exec VP, effective September 4.

Campion came to BD after it acquired C.R. Bard, and has served as the surgery biz worldwide president, the company said. Prior to the acquisition, he led Bard’s surgery business for five years, having joined the company in 2008.

“Simon is a proven leader with deep global experience, a demonstrated focus on results and unique insight and breadth across the BD interventional segment. He is well prepared to drive innovation and cultural initiatives across the peripheral intervention, urology and critical care, and surgery businesses, while continuing to deliver growth as we integrate these businesses into BD,” prez Tom Polen said in a press release.

Repro Med Systems (OTC:REPR) said last week it lifted board member Daniel Goldberger to the position of chair and interim prez and CEO

Goldberger joined the board in April, and has previously held positions with companies including Xtant Medical Holdings, Sound Surgical Tech, Xcorporeal and Glucon.

“I look forward to building on the foundation that Andy has laid over thirty years and we appreciate his service. The invention of the Freedom60 has improved the lives of thousands of chronically-ill patients around the globe, and RMS’ portfolio of products has enormous application potential. Andy’s long list of accomplishments has positioned RMS well for strong long-term growth of revenue and shareholder value,” Goldberger said in a press release.

“The prospects for the company are very bright, and we are excited to engage new leadership to embark on our next phase of significant growth,” board member Joseph Manko said in a prepared statement.

Royal Philips (NYSE:PHG) said last week that Jeffrey Barnes is succeeding Iain Burns as Philips Canada prez & CEO, effective immediately.

Barnes serves as a member of Philips NA exec team and is replacing Burns, who retired on July 31. Barnes had previously served as NA commercial leader senior VP.

“Jeff is a proven leader with nearly three decades of experience in working with high-performance, cross-functional teams, and he has worked closely with our North American partners to understand the solutions they need to stay ahead of a rapidly changing industry, helping them to deliver better healthcare for their communities. I am confident that Jeff will build on the exceptional contributions made by Iain Burns to Philips – in Canada, North America and around the globe. I want to commend Iain for his accomplishments, thank him for his continued commitment to the Canadian business and wish him all the best as he begins to plan for retirement,” Philips NA CEO Vitor Rocha said in a press release.

Medtech startup Lineus Medical has appointed former COO Vance Clement as its new chief exec as the comapny looks to move out of the R&D phase and into the product launch phase, according to a recent TalkBusiness report.

Former CEO and founder Spencer Jones, who invented the company’s SafeBreak Vascular product will move to a chief technical officer role, according to the report.

“The board made the move so that Spencer could continue to focus on his strengths such as product development, clinical issues and intellectual property. We moved people to their area of strength to match the company’s current focus,” Clement said, according to TalkBusiness.

Read more